Tempus AI: Buy On Diagnostics Momentum And AI Platform Expansion
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-30T07:50:49.000Z","dateModified":"2026-06-30T07:52:37.000Z","description":"Recent FDA approval for xT CDx's tumor-only indication and the upcoming xH assay broaden Tempus AI's clinical reach. J Studios/DigitalVision via Getty Images I've written about Tempus (TEM) in the past and how I like it as a play on the combination of healthcare and AI.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-06-30T07:50:49.000Z","dateModified":"2026-06-30T07:52:37.000Z","description":"Recent FDA approval for xT CDx's tumor-only indication and the upco
- ▪J Studios/DigitalVision via Getty Images I've written about Tempus (TEM) in the past and how I like it as a play on the combination of healthcare and AI.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4918716-tempus-ai-buy-on-diagnostics-momentum-and-ai-platform-expansion"},"author":{"@type":"Person","name":"Value…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
